Latest headlines
Merck News
The latest Merck (MRK) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these MRK headlines next to the live Merck Fear and Greed Index.
Latest Merck Headlines60
Merck: 'Strong Buy' Lipfendra FDA First And Continued Oncology Expansions
seekingalpha.com · Jul 17, 2026
MRK Stock Jumps on FDA Nod for Cholesterol-Lowering Pill
zacks.com · Jul 17, 2026
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?
247wallst.com · Jul 17, 2026
Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy
proactiveinvestors.com · Jul 17, 2026
Use These ETFs as Health Stocks LLY, UNH, MRK Thrive
etftrends.com · Jul 17, 2026
New Cholesterol Pill, Earnings Growth Boost Merck Shares
fxempire.com · Jul 17, 2026
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio
benzinga.com · Jul 16, 2026
FDA signs off on Merck's cholesterol-lowering pill — the first oral treatment of its kind
nypost.com · Jul 16, 2026
Nasdaq slides as chip selloff drags Wall Street lower
proactiveinvestors.com · Jul 16, 2026
Nasdaq dragged by chip sell-off, Abbott, UnitedHealth lead risers
proactiveinvestors.com · Jul 16, 2026
Merck's cholesterol pill gets US FDA approval
reuters.com · Jul 16, 2026
The FDA approved Lipfendra, a first-of-its kind pill from Merck that is designed to help lower cholesterol levels beyond what statins alone can achieve
wsj.com · Jul 16, 2026
Merck Gets Approval for Powerful Cholesterol-Cutting Pill
barrons.com · Jul 16, 2026
Merck's LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia
businesswire.com · Jul 16, 2026
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer
benzinga.com · Jul 15, 2026
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
businesswire.com · Jul 15, 2026
FDA Expands MRK & PFE's Keytruda-Padcev Combo Use in Bladder Cancer
zacks.com · Jul 13, 2026
Why Merck Stock Is in the Spotlight Today
benzinga.com · Jul 13, 2026
Merck (MRK) Stock Sinks As Market Gains: Here's Why
zacks.com · Jul 10, 2026
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)
businesswire.com · Jul 10, 2026
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
zacks.com · Jul 10, 2026
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
zacks.com · Jul 9, 2026
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
fool.com · Jul 9, 2026
MRK Surpasses 50- & 200-Day SMAs: Buy, Hold or Sell at Current Levels?
zacks.com · Jul 8, 2026
Merck To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday
benzinga.com · Jul 8, 2026
The Dividend ETF Quietly Outperforming the S&P 500
fool.com · Jul 7, 2026
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
zacks.com · Jul 6, 2026
Why MSTY Shareholders Are Facing Uncapped Losses Despite Weekly Distributions
247wallst.com · Jul 5, 2026
Merck & Co Inc (MRK) Shares Surge 3.3% -- What GF Score of 78 Tells Investors
gurufocus.com · Jul 2, 2026
Merck Stock, JPMorgan And Two Others Hit New Highs
investors.com · Jul 2, 2026
Schwab vs. Vanguard: Which Dividend ETF Is Best for Your Portfolio?
fool.com · Jul 1, 2026
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
businesswire.com · Jul 1, 2026
Merck, AbbVie probed by US lawmakers over China clinical trials: report
proactiveinvestors.com · Jun 30, 2026
Stock Futures Quiet to End the Month, Quarter
schaeffersresearch.com · Jun 30, 2026
Merck, AbbVie probed by US lawmakers over China clinical trials: report
proactiveinvestors.com · Jun 30, 2026
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Jun 30, 2026
Merck & Company (MRK) Price Forecast: Can Momentum Drive New Highs?
fxempire.com · Jun 29, 2026
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
zacks.com · Jun 29, 2026
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV
businesswire.com · Jun 29, 2026
Merck (MRK) Gains As Market Dips: What You Should Know
zacks.com · Jun 26, 2026
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · Jun 26, 2026
Qualcomm, Merck, Rockwell Automation And A Real Estate Stock On CNBC's ‘Final Trades'
benzinga.com · Jun 26, 2026
The Big 3: JPM, DHR, MRK
youtube.com · Jun 25, 2026
MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder Cancer
zacks.com · Jun 25, 2026
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
businesswire.com · Jun 25, 2026
Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBC
zacks.com · Jun 24, 2026
Here Are Wednesday’s Best Wall Street Analyst Research Calls: Devon Energy, Flowserve, Klaviyo, Macerich, Merck, Nucor, Take-Two Interactive Software, Twilio, and More
247wallst.com · Jun 24, 2026
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer
businesswire.com · Jun 24, 2026
EXEL Down on Colorectal Cancer Study Data on Zanzalintinib
zacks.com · Jun 23, 2026
Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study
zacks.com · Jun 23, 2026
Merck and Mae Partner to Expand Doula Workforce and Address Maternal Health Disparities in High-Risk U.S. Markets
businesswire.com · Jun 23, 2026
Bank of America Sees Interest Rates Exploding Higher Soon: Play It Safe With 4 Dividend Giants
247wallst.com · Jun 23, 2026
AbbVie and Merck Face-Off: Which Pharma Stock Has the Lead?
zacks.com · Jun 22, 2026
Merck's Oncology Engine Is Still Accelerating
seekingalpha.com · Jun 22, 2026
Merck's bowel disease drug meets main goal in late-stage trial
reuters.com · Jun 22, 2026
Merck's Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
businesswire.com · Jun 22, 2026
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
zacks.com · Jun 18, 2026
FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens
benzinga.com · Jun 18, 2026
Merck's pneumococcal vaccine wins US approval for high-risk children, teens
reuters.com · Jun 18, 2026
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
businesswire.com · Jun 18, 2026
Why Is Merck Up or Down Today?
When Merck (MRK) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a MRK move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Merck is up or down today.
How Merck News Affects the Price
News does not move the Merck (MRK) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Merck Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Merck trading volume. That is the chain to watch: headline, sentiment, volume, then the MRK price.
Trade the Merck News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Merck trading volume spike on a big story, check the Merck price history for context, follow the live MRK price, see the Merck price prediction, and read the Merck Fear and Greed Index for mood.
How do you feel about Merck?
1DFrequently asked questions
Why is Merck up or down today?
What is the latest Merck news?
Where does Merck news come from?
How often is Merck news updated?
How does Merck news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.